Home Clinical Topics Drugs and Devices

Drugs and Devices

Cannabinoid hyperemesis syndrome explained

Learn how to identify this frequently misdiagnosed condition. Takeaways: Cannabinoid hyperemesis syndrome is a growing but poorly understood healthcare concern within the rising number of...

New treatment for multiple myeloma

The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of  adult patients with multiple myeloma. Isatuximab-irfc was previously...

The changing face of cystic fibrosis

It’s no longer a childhood illness. Takeaways: The Cystic Fibrosis Foundation Patient Data Registry shows that more than 54% of people with cystic fibrosis live...

Avoiding antipsychotic medication use in nursing home residents with dementia

Nurses are critical to improved resident well-being. Takeaways: Elderly patients using antipsychotic medications are at a 1.6 to 1.7 times increased of risk of death,...

Study shows reduced risk of cardiovascular disease during times of bereavement with daily aspirin intake

A study published in the American Heart Journal explored the effects of aspirin and low dose metoprolol intake during early bereavement periods. Times of bereavement...

New vaccine eliminated breast cancer in first human patient

A vaccine being developed in the Mayo Clinic in Jacksonville, Florida is aimed at preventing new cases of ovarian and breast cancer and even...

New treatment for peanut allergy in children

The U.S. Food and Drug Administration (FDA) recently approved Aimmune Therapeutics’ Palforzia for children suffering from peanut allergy. Palforzia is intended to help...

Ultrasound-guided I.V. catheter insertion

Standardized protocols and education can improve patient safety, reduce costs, and enhance nursing practice. Takeaways: Achieving peripheral I.V. access can be difficult, even for experienced...

FDA launches mobile app on antiretrovirals

On Jan. 29, the FDA launched an interactive database that will offer a wealth of critical information about antiretrovirals eligible for purchase under the...

New treatment for advanced epithelioid sarcoma

The U.S. Food and Drug Administration (FDA) recently approved Epizyme, Inc’s tazemetostat (TAZVERIK) for the treatment of adult and pediatric patients with metastatic or...